Oliver M. Fisher, MD, PhD, FMH (Surgery), FRACS (@omaxfisher) 's Twitter Profile
Oliver M. Fisher, MD, PhD, FMH (Surgery), FRACS

@omaxfisher

Surgeon-Scientist, GI Surgical Oncology & Upper GI Surgery, Oncogenomics Dreamer, Bioinformatics & Stats Lover, Father of 3 & Husband of 1 Awesome Burns Surgeon

ID: 1546951136

calendar_today26-06-2013 00:19:15

2,2K Tweet

835 Takipçi

483 Takip Edilen

Ahmad Abou Abbass (@ahmadabouabbas8) 's Twitter Profile Photo

Extreme robotic surgery! Whipple in a patient with history of previous Ivor Lewis so I had to preserve the GDA and right gastroepiploic artey which is the sole blood supply to the stomach.. #robot4HPB

Peter Cashin (@cashinptr) 's Twitter Profile Photo

My good friend Oliver! Thank you for your long persistance! We have tried to work this cohort from every angel. We have just not seen that mitomycin is superior to oxaliplatin in any subgroup. Prodige 7 made centers switch to mitomycin, but we just don’t have the data for switch

Oliver M. Fisher, MD, PhD, FMH (Surgery), FRACS (@omaxfisher) 's Twitter Profile Photo

Pls read this excellent commentary by Beate Rau. She nails the topic&issues on the head. #HIPEC should be delivered at a minimum in a registry but even better trial setting as the effects are unclear. Markus W. Löffler, MD & I have written about this in the past doi.org/10.1007/s12254…

Syed A. Ahmad (@syedaahmad5) 's Twitter Profile Photo

A comparison of outcomes including bile duct injury of subtotal cholecystectomy versus open total cholecystectomy as bailout procedures for severe cholecystitis: A multicenter real-world study ⁦SURGERY Journal⁩ surgjournal.com/article/S0039-…

Krishan Jethwa (@krishanjethwa) 's Twitter Profile Photo

🚨🚨🚨 #ESOPEC🚨🚨🚨 🔥Practice shifting trial🔥 Patients with resectable, locally advanced, esophagus/GEJ adenocarcinoma Randomized Peri-op FLOT (FLOT4) vs Pre-operative chemoradiation (CROSS) Congrats to the study investigators! Let’s dive in! #ASCO24 Mayo Clinic Radiation Oncology 1/

🚨🚨🚨 #ESOPEC🚨🚨🚨

🔥Practice shifting trial🔥

Patients with resectable, locally advanced, esophagus/GEJ adenocarcinoma

Randomized 

Peri-op FLOT (FLOT4)
vs
Pre-operative chemoradiation (CROSS)

Congrats to the study investigators!

Let’s dive in!

#ASCO24 <a href="/MayoRadOnc/">Mayo Clinic Radiation Oncology</a>

1/
Brendon Stiles (@brendonstilesmd) 's Twitter Profile Photo

I've never believed in neoadjuvant CRT for patients w/ esophageal adenocarcinoma, thinking heavily influenced by nasser altorki & Lorenzo Ferri MD PhD. Certainly ESOPEC supports that stance, although differing systemic regimens complicates. pubmed.ncbi.nlm.nih.gov/30278165/ pubmed.ncbi.nlm.nih.gov/26916717/

Oliver M. Fisher, MD, PhD, FMH (Surgery), FRACS (@omaxfisher) 's Twitter Profile Photo

In view of also increased risk of periop resp complications in CRTx, for me the CROSS treatment protocol will now be shelved for resectable GOJ adeno-ca in favour of FLOT.

Ali Aminian (@ali_aminian_md) 's Twitter Profile Photo

MOSAIC was published today in JACC Journals Bariatric surgery in patients with obstructive #sleep apnea (#OSA) and #obesity: ✨42% ⬇️ MACE ✨37% ⬇️ Death ✨70% ⬇️ Heart Failure ✨24% weight loss at 10-years dx.doi.org/10.1016/j.jacc… #cardiactwitter

MOSAIC was published today in <a href="/JACCJournals/">JACC Journals</a> 

Bariatric surgery in patients with obstructive #sleep apnea (#OSA) and #obesity: 

✨42% ⬇️ MACE

✨37% ⬇️ Death

✨70% ⬇️ Heart Failure 

✨24% weight loss at 10-years

dx.doi.org/10.1016/j.jacc… #cardiactwitter
Syed A. Ahmad (@syedaahmad5) 's Twitter Profile Photo

Laparoscopic Spleen-Preserving Hilar Lymphadenectomy for Advanced Proximal Gastric Cancer Without Greater Curvature Invasion: Five-Year Outcomes From the Fuges-02 Randomized Clinical Trial ⁦JAMA Surgery⁩ jamanetwork.com/journals/jamas…

Lee M. Ocuin MD, FACS (@thenotorioushpb) 's Twitter Profile Photo

Nice study on futility model for up-front resection in “resectable” PDAC. Occurs ~20% of the time and ~30% of patients never see systemic therapy. The sequence matters! Victoria Wu Stefano Crippa Giuseppe Malleo Roberto Salvia Syed A. Ahmad Flavio G Rocha, MD, FACS, FSSO jamanetwork.com/journals/jamas…

Tanya (@gonggasgirl) 's Twitter Profile Photo

Are you a plastic surgeon who likes beaches, being an hour from Sydney airport, and hanging out with spicy anaesthetists? Come and play with us in Wollongong.

Lee M. Ocuin MD, FACS (@thenotorioushpb) 's Twitter Profile Photo

Robert Sutcliffe IHPBA GBIHPBA E-AHPBA Pancreatic Cancer UK EPC-Europ Pancr Club Pancreas Verona panc Data suggests “high risk” glands should leak less than 50% of the time (if you are technically competent), so committing a high-risk patient to 100% chance of EPI and DM seems a bit extreme as a baseline approach. If you can’t sew and/or gland falls apart, I guess bets are off…

Oliver M. Fisher, MD, PhD, FMH (Surgery), FRACS (@omaxfisher) 's Twitter Profile Photo

Early 50s. No comorbs. Biopsy proven poorly diff OAC (no signet). Has this biopsy proven node below clavicles. “Locoregional” or M1? Curative intent FLOT followed by surgery or palliative? How long FLOT if 4 surgery? Lorenzo Ferri MD PhD Ewen A Griffiths Tim Underwood Sheraz Markar

Early 50s. No comorbs. Biopsy proven poorly diff OAC (no signet). Has this biopsy proven node below clavicles. “Locoregional” or M1? Curative intent FLOT followed by surgery or palliative? How long FLOT if 4 surgery? <a href="/LFerri123/">Lorenzo Ferri MD PhD</a> <a href="/EwenGriffiths/">Ewen A Griffiths</a> <a href="/TimTheSurgeon/">Tim Underwood</a> <a href="/MarkarSheraz/">Sheraz Markar</a>
Oliver M. Fisher, MD, PhD, FMH (Surgery), FRACS (@omaxfisher) 's Twitter Profile Photo

The Residency Interview youtu.be/k2BEA8mNXPg?si… via Dr. Glaucomflecken addressing one of things I always say: not everyone has to be an academic! We also just need good doctors who know how to take care of patients!

Lee M. Ocuin MD, FACS (@thenotorioushpb) 's Twitter Profile Photo

The cynic in me has only one question: how many more radiotherapy trials will be conducted despite the repetitive finding that RT does not improve survival?